Gene · 9123
Papers3,520
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 3,520
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Comprehensive investigation of the molecular basis of cancer dependencies suggests therapeutic options for breast cancer. | Cancer Biol Med | 2025 | 41131861 | PubTator, text mining | PubMed |
| Twice-a-day exercise increases acute MCT1 gene expression in skeletal muscle but does not change the lactate curve after 3 weeks of training in adult men. | Braz J Med Biol Res | 2025 | 41124439 | PubTator, text mining | PubMed |
| Identification and characterization of lLF2 as a prognostic biomarker in HER2-positive breast cancer using Mendelian randomization and machine learning. | Discov Oncol | 2025 | 41117990 | PubTator, text mining | PubMed |
| SPP1 as a Potential Stage-Specific Marker of Colorectal Cancer. | Cancers (Basel) | 2025 | 41097728 | PubTator, text mining | PubMed |
| The role of solute carrier family 16 member 3 protein in hepatocellular carcinoma and sorafenib resistance. | Int J Biol Macromol | 2025 | 41075888 | PubTator, text mining | PubMed |
| RETRACTION: Positive Feedback in Cav-1-ROS Signalling in PSCs Mediates Metabolic Coupling between PSCs and Tumour Cells. | J Cell Mol Med | 2025 | 41039993 | PubTator, text mining | PubMed |
| Selective regulation and cellular metabolism by the lactate transporter MCT4 in GBM. | Med Oncol | 2025 | 41003809 | PubTator, text mining | PubMed |
| The effect of glycolytic enzyme expression and thyroiditis on the aggressiveness of papillary thyroid carcinoma: a retrospective cohort study. | Ann Surg Treat Res | 2025 | 41000235 | PubTator, text mining | PubMed |
| Lactylation-driven MVP upregulation boosts immunotherapy resistance by inhibiting PD-L1 degradation in hepatocellular carcinoma. | J Immunother Cancer | 2025 | 40983342 | PubTator, text mining | PubMed |
| Lactic acid regulates antitumor immunity in canine invasive urothelial carcinoma. | PLoS One | 2025 | 40966256 | PubTator, text mining | PubMed |
| SLC16A3 (MCT4) expression in tumor immunity and Metabolism: Insights from pan-cancer analysis. | Biochem Biophys Rep | 2025 | 40927315 | PubTator, text mining | PubMed |
| SLC16A3 as an immunosuppressive Kupffer cell marker predicts poor prognosis in HBV-positive hepatocellular carcinoma. | J Transl Med | 2025 | 40898206 | PubTator, text mining | PubMed |
| Glucose Metabolic Reprogramming in Colorectal Cancer: From Mechanisms to Targeted Therapy Approaches. | Cancer Med | 2025 | 40884151 | PubTator, text mining | PubMed |
| Targeting the SYVN1-EGFR axis: a breakthrough strategy for TKI-resistant NSCLC. | Cell Death Dis | 2025 | 40877231 | PubTator, text mining | PubMed |
| Associations Between Genetic Variants in MCT2 (rs3763980, rs995343, rs3763979) and MCT4 (rs11323780) with Blood Lactate Kinetics Before and After Supramaximal Exercise. | Int J Mol Sci | 2025 | 40869186 | PubTator, text mining | PubMed |
| Ketogenic Metabolism in Neurodegenerative Diseases: Mechanisms of Action and Therapeutic Potential. | Metabolites | 2025 | 40863128 | PubTator, text mining | PubMed |
| Therapeutic Strategies Targeting Aerobic Glycolysis in Cancer and Dynamic Monitoring of Associated Metabolites. | Cells | 2025 | 40862767 | PubTator, text mining | PubMed |
| Targeting LINC01711 in FAP+ cancer-associated fibroblasts overcomes lactate-mediated immunosuppression and enhances anti-PD-1 efficacy in lung adenocarcinoma. | Cell Death Dis | 2025 | 40855046 | PubTator, text mining | PubMed |
| Large-scale GWAS of strabismus identifies risk loci and provides support for a link with maternal smoking. | Nat Commun | 2025 | 40849414 | PubTator, text mining | PubMed |
| CD24 recruits tumor-associated neutrophils to promote the progression of hepatocellular carcinoma. | J Immunother Cancer | 2025 | 40841133 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9123/papers?page=9